Matthias Ilmer

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 12

Top Topics

Cancer Stem Cells

Positive Breast Cancer

Reduced Graphene Oxide

Top Venues

International journal of nanomedicine

Breast cancer research : BCR

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dominik T Koch, Haochen Yu, Iris Beirith, Malte Schirren, Moritz Drefs, Yunfei Liu, Mathilda Knoblauch, Dionysios Koliogiannis, Weiwei Sheng, Enrico N De Toni, Alexandr V Bazhin, Bernhard W Renz, Markus O Guba, Jens Werner, Matthias Ilmer
Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells. Journal of translational medicine 21 (1) (2023)
Jing Wang, Weijian Chen, Wenxiang Du, Hongjie Zhang, Matthias Ilmer, Lei Song, Yuan Hu, Xiaopeng Ma
ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy. International journal of nanomedicine 18 (2023)
Jing Wang, Weijian Chen, Wenxiang Du, Hongjie Zhang, Matthias Ilmer, Lei Song, Yuan Hu, Xiaopeng Ma
ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy. International journal of nanomedicine 18 (2023)
Jing Wang, Weijian Chen, Wenxiang Du, Hongjie Zhang, Matthias Ilmer, Lei Song, Yuan Hu, Xiaopeng Ma
ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy. International journal of nanomedicine 18 (2023)
Sebastian Wolf, Verena S Hoffmann, Florian Sommer, Matthias Schrempf, Mingming Li, Martin Ryll, Ulrich Wirth, Matthias Ilmer, Jens Werner, Joachim Andrassy
Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation-A Network Meta-Analysis. Journal of clinical medicine 11 (14) (2022)
Tianmiao Ma, Bernhard W Renz, Matthias Ilmer, Dominik Koch, Yuhui Yang, Jens Werner, Alexandr V Bazhin
Myeloid-Derived Suppressor Cells in Solid Tumors. Cells 11 (2) (2022)
Matthias Ilmer, Markus Otto Guba
Liver Transplant Oncology: Towards Dynamic Tumor-Biology-Oriented Patient Selection. Cancers 14 (11) (2022)
Bernhard W Renz, Christine Adrion, Carsten Klinger, Matthias Ilmer, Jan G D'Haese, Heinz-J Buhr, Ulrich Robert Mansmann, Jens Werner, null null
Pylorus resection versus pylorus preservation in pancreatoduodenectomy (PyloResPres): study protocol and statistical analysis plan for a German multicentre, single-blind, surgical, registry-based randomised controlled trial. BMJ open 11 (11) (2021)
Iris Beirith, Bernhard W Renz, Shristee Mudusetti, Natalja Sergejewna Ring, Julian Kolorz, Dominik Koch, Alexandr V Bazhin, Michael Berger, Jing Wang, Martin K Angele, Jan G D'Haese, Markus O Guba, Hanno Niess, Joachim Andrassy, Jens Werner, Matthias Ilmer
Identification of the Neurokinin-1 Receptor as Targetable Stratification Factor for Drug Repurposing in Pancreatic Cancer. Cancers 13 (11) (2021)
Julian Kolorz, Salih Demir, Adrian Gottschlich, Iris Beirith, Matthias Ilmer, Daniel Lüthy, Christoph Walz, Mario M Dorostkar, Thomas Magg, Fabian H Hauck, Dietrich von Schweinitz, Sebastian Kobold, Roland Kappler, Michael Berger
The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors. Current oncology (Toronto, Ont.) 29 (1) (2021)
Bernhard W Renz, Takayuki Tanaka, Masaki Sunagawa, Ryota Takahashi, Zhengyu Jiang, Marina Macchini, Zahra Dantes, Giovanni Valenti, Ruth A White, Moritz A Middelhoff, Matthias Ilmer, Paul E Oberstein, Martin K Angele, Huan Deng, Yoku Hayakawa, Christoph Benedikt Westphalen, Jens Werner, Helen E Remotti, Maximilian Reichert, Yagnesh H Tailor, Karan Nagar, Richard A Friedman, Alina C Iuga, Kenneth P Olive, Timothy C Wang
Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness. Cancer discovery 8 (11) (2018)
Matthias Ilmer, Nachman Mazurek, Michael Z Gilcrease, James C Byrd, Wendy A Woodward, Thomas A Buchholz, Kim Acklin, Karen Ramirez, Margarete Hafley, Eckhard Alt, Jody Vykoukal, Robert S Bresalier
Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells. Breast cancer research : BCR 18 (1) (2016)